The FDA is expected to decide on treatments for COPD, psoriasis, rare neuroendocrine tumors, and a next-generation COVID-19 vaccine.

The most common causes of chronic cough include gastroesophageal reflux disease (GERD), asthma, and postnasal drip (also ...

Blagosklonny goes on to write that even though rapamycin may reverse some manifestations of aging, it is more effective at ...

Discover how Temple Lung Center’s innovative clinical trials provide early access to breakthrough treatments and enhanced ...

Columnist Caroline Gainer's first kettlebell workout went far better than she expected. Sometimes trying something new pays ...

FDA aligned on plan to initiate parallel Phase 2 trials of rademikibart in patients with moderate-to-severe asthma or COPD experiencing an acute exacerbation -- Expect to initia ...

Chronic obstructive pulmonary disease (COPD) is a major cause of death among patients with renal cell carcinoma (RCC) in the United States, investigators reported at ASCO’s 2025 Genitourinary Cancers ...

Adults with refractory chronic cough who received twice-daily camlipixant had decreases in cough frequency and better scores ...

Dr Simon Rudland from Stowmarket says N-Tidal Diagnose could help GPs diagnose patients with COPD from their local clinic if it is approved.

Experts share their tips for breathing easier - even if you have a chronic condition such as asthma or chronic obstructive ...

Given the rising prevalence of cognitive impairment in COPD, researchers have called for increased efforts to identify risk ...

Strengthened leadership team with key appointments, including Barry Quart, Pharm.D. as CEO, and David Szekeres as President, bringing deep clinical, regulatory, operational and strategic expertise ...